OLPAOffice of Legislative Policy and Analysis
FAQs | Site Map | Links | Home
September 3, 2014
skip navigation

  (spacer) Bill Tracking

  (spacer) Legislative Updates

  arrow Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH


  (spacer) OLPA


margin frame

Congressional ActionsPublic Laws
(spacer)

108th Congress

arrow indicating current page Session I | Session II

P.L. 108-25 - United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003

On May 27, 2003, the President signed into law H.R. 1298 as P.L. 108-25, the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003. Provisions of this new legislation would 1) require the President to establish a comprehensive, integrated 5-year strategy to combat global HIV/AIDS, including specific objectives, approaches and strategies; 2) assign priorities for relevant executive branch agencies; 3) improve coordination among such agencies; and 4) project general levels of resources needed to achieve the stated goals. This legislation also would require the President to establish a position of HIV/AIDS Response Coordinator at the U.S. Department of State, who would have primary responsibility for oversight and coordination of all U.S. international activities to combat the HIV/AIDS pandemic.

Legislative Update (August 2003): United States Leadership Against Global HIV/AIDS, Tuberculosis, and Malaria Act of 2003

For further information, go to the Thomas Web Site.

For a chronology of legislation affecting NIH, refer to the NIH Almanac.

(spacer)

 

Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy